# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
79, Journal, 0, 13, "Diabetes Care", "", "<http://ctro/data#Publication_36381> <http://ctro/data#hasJournal> \"Diabetes Care\"."
0, PublicationYear, 16, 20, "2006", "", "<http://ctro/data#Publication_36381> <http://ctro/data#hasPublicationYear> \"2006\"."
175, Title, 49, 185, "Efficacy of benfluorex in combination with sulfonylurea in type 2 diabetic patients : an 18 - week , randomized , double - blind study .", "", "<http://ctro/data#Publication_36381> <http://ctro/data#hasTitle> \"Efficacy of benfluorex in combination with sulfonylurea in type 2 diabetic patients : an 18 - week , randomized , double - blind study .\"."
81, Drug, 61, 71, "benfluorex", "", 
82, Sulfonylureas, 92, 104, "sulfonylurea", "", 
83, Type2Diabetes, 108, 123, "type 2 diabetic", "", 
84, Duration, 138, 147, "18 - week", "", 
85, Randomized, 150, 160, "randomized", "", 
86, DoubleBlind, 163, 177, "double - blind", "", 
1, Author, 186, 194, "Moulin P", "", "<http://ctro/data#Publication_36381> <http://ctro/data#hasAuthor> \"Moulin P\"."
2, Author, 203, 210, "Andre M", "", "<http://ctro/data#Publication_36381> <http://ctro/data#hasAuthor> \"Andre M\"."
3, Author, 213, 220, "Alawi H", "", "<http://ctro/data#Publication_36381> <http://ctro/data#hasAuthor> \"Alawi H\"."
4, Author, 223, 236, "dos Santos LC", "", "<http://ctro/data#Publication_36381> <http://ctro/data#hasAuthor> \"dos Santos LC\"."
5, Author, 239, 248, "Khalid AK", "", "<http://ctro/data#Publication_36381> <http://ctro/data#hasAuthor> \"Khalid AK\"."
6, Author, 251, 257, "Koev D", "", "<http://ctro/data#Publication_36381> <http://ctro/data#hasAuthor> \"Koev D\"."
7, Author, 260, 267, "Moore R", "", "<http://ctro/data#Publication_36381> <http://ctro/data#hasAuthor> \"Moore R\"."
8, Author, 270, 278, "Serban V", "", "<http://ctro/data#Publication_36381> <http://ctro/data#hasAuthor> \"Serban V\"."
9, Author, 281, 291, "Picandet B", "", "<http://ctro/data#Publication_36381> <http://ctro/data#hasAuthor> \"Picandet B\"."
10, Author, 294, 307, "Francillard M", "", "<http://ctro/data#Publication_36381> <http://ctro/data#hasAuthor> \"Francillard M\"."
11, France, 425, 431, "France", "", "<http://ctro/data#Population_36416> <http://ctro/data#hasCountry> <http://ctro/data#France>."
45705, ObjectiveDescription, 482, 633, "The aim of this study was to demonstrate the superiority of benfluorex over placebo as an add - on therapy in type 2 diabetic patients in whom diabetes", "", "<http://ctro/data#ClinicalTrial_36397> <http://ctro/data#hasObjectiveDescription> \"The aim of this study was to demonstrate the superiority of benfluorex over placebo as an add - on therapy in type 2 diabetic patients in whom diabetes\"."
14, Drug, 542, 552, "benfluorex", "", 
15, Placebo, 558, 565, "placebo", "", 
12, Precondition, 592, 741, "type 2 diabetic patients in whom diabetes is insufficiently controlled by sulfonylurea monotherapy and who have a limitation for the use of metformin", "", 
18, Type2Diabetes, 592, 607, "type 2 diabetic", "", 
102, Type2Diabetes, 625, 633, "diabetes", "", 
45706, ObjectiveDescription, 625, 743, "diabetes is insufficiently controlled by sulfonylurea monotherapy and who have a limitation for the use of metformin .", "", "<http://ctro/data#ClinicalTrial_36397> <http://ctro/data#hasObjectiveDescription> \"diabetes is insufficiently controlled by sulfonylurea monotherapy and who have a limitation for the use of metformin .\"."
16, Sulfonylureas, 666, 678, "sulfonylurea", "", 
17, Metformin, 732, 741, "metformin", "", 
19, Type2Diabetes, 774, 789, "Type 2 diabetic", "", 
20, Precondition, 774, 955, "Type 2 diabetic patients with HbA ( 1c ) ( A1C ) ( 7 - 10 % ) who were receiving the maximum tolerated sulfonylurea dose and had a contraindication to or poor tolerance of metformin", "", "<http://ctro/data#Population_36416> <http://ctro/data#hasPrecondition> \"Type 2 diabetic patients with HbA ( 1c ) ( A1C ) ( 7 - 10 % ) who were receiving the maximum tolerated sulfonylurea dose and had a contraindication to or poor tolerance of metformin\"."
21, HbA1c, 804, 814, "HbA ( 1c )", "", "<http://ctro/data#Endpoint_36424> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c>."
178, HbA1c, 817, 820, "A1C", "", 
177, Percentage, 832, 833, "%", "", 
22, Sulfonylureas, 877, 889, "sulfonylurea", "", 
23, Metformin, 946, 955, "metformin", "", 
24, Randomized, 961, 969, "randomly", "", "<http://ctro/data#ClinicalTrial_36397> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
25, DoubleBlind, 981, 993, "double blind", "", "<http://ctro/data#ClinicalTrial_36397> <http://ctro/data#hasCTDesign> <http://ctro/data#DoubleBlind>."
26, Drug, 1007, 1017, "benfluorex", "", "<http://ctro/data#Drug_36480> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Drug>. <http://ctro/data#Medication_36479> <http://ctro/data#hasDrug> <http://ctro/data#Drug_36480>."
27, DoseValue, 1018, 1021, "450", "", "<http://ctro/data#Medication_36479> <http://ctro/data#hasDoseValue> \"450\"."
28, mg, 1022, 1024, "mg", "", "<http://ctro/data#Medication_36479> <http://ctro/data#hasDoseUnit> <http://ctro/data#mg>."
78, Interval, 1027, 1030, "day", "", "<http://ctro/data#Intervention_36467> <http://ctro/data#hasInterval> \"day\"."
29, NumberPatientsArm, 1037, 1040, "165", "", "<http://ctro/data#Arm_36449> <http://ctro/data#hasNumberPatientsArm> \"165\"."
30, Placebo, 1046, 1053, "placebo", "", "<http://ctro/data#Medication_36486> <http://ctro/data#hasDrug> <http://ctro/data#Placebo>."
31, NumberPatientsArm, 1060, 1063, "160", "", "<http://ctro/data#Arm_36458> <http://ctro/data#hasNumberPatientsArm> \"160\"."
32, Duration, 1070, 1078, "18 weeks", "", "<http://ctro/data#ClinicalTrial_36397> <http://ctro/data#hasCTduration> \"18 weeks\"."
33, HbA1c, 1113, 1116, "A1C", "", 
183, TimePoint, 1147, 1155, "baseline", "", 
184, TimePoint, 1163, 1179, "end of treatment", "", 
34, MeasurementDevice, 1186, 1192, "ANCOVA", "", "<http://ctro/data#MeasurementDevice_36428> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice>. <http://ctro/data#Endpoint_36424> <http://ctro/data#hasMeasurementDevice> <http://ctro/data#MeasurementDevice_36428>."
35, FastingPlasmaGlucose, 1259, 1281, "fasting plasma glucose", "", 
36, FastingPlasmaGlucose, 1284, 1287, "FPG", "", 
37, EndPointDescription, 1292, 1310, "insulin resistance", "", 
38, EndPointDescription, 1317, 1335, "plasma lipid level", "", 
185, TimePoint, 1376, 1384, "baseline", "", 
128, IntentionToTreat, 1392, 1414, "intention - to - treat", "", "<http://ctro/data#ClinicalTrial_36397> <http://ctro/data#hasAnalysisApproach> <http://ctro/data#IntentionToTreat>."
39, HbA1c, 1428, 1431, "A1C", "", 
40, Drug, 1461, 1471, "benfluorex", "", 
41, BaseLineValue, 1477, 1483, "8 . 34", "", "<http://ctro/data#Outcome_37550> <http://ctro/data#hasBaselineValue> \"8 . 34\"."
42, SdDevBL, 1490, 1496, "0 . 83", "", "<http://ctro/data#Outcome_37550> <http://ctro/data#hasSdDevBL> \"0 . 83\"."
43, ResultMeasuredValue, 1500, 1506, "7 . 52", "", "<http://ctro/data#Outcome_37550> <http://ctro/data#hasResultMeasuredValue> \"7 . 52\"."
44, SdDevResValue, 1513, 1519, "1 . 04", "", "<http://ctro/data#Outcome_37550> <http://ctro/data#hasSdDevResValue> \"1 . 04\"."
45, Percentage, 1520, 1521, "%", "", "<http://ctro/data#Endpoint_36424> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Percentage>."
136, PValueChangeValue, 1524, 1535, "P < 0 . 001", "", "<http://ctro/data#Outcome_37550> <http://ctro/data#hasPValueChangeValue> \"P < 0 . 001\"."
47, Placebo, 1566, 1573, "placebo", "", 
48, BaseLineValue, 1579, 1585, "8 . 33", "", "<http://ctro/data#Outcome_37577> <http://ctro/data#hasBaselineValue> \"8 . 33\"."
49, SdDevBL, 1592, 1598, "0 . 87", "", "<http://ctro/data#Outcome_37577> <http://ctro/data#hasSdDevBL> \"0 . 87\"."
50, ResultMeasuredValue, 1602, 1608, "8 . 52", "", "<http://ctro/data#Outcome_37577> <http://ctro/data#hasResultMeasuredValue> \"8 . 52\"."
51, SdDevResValue, 1615, 1621, "1 . 36", "", "<http://ctro/data#Outcome_37577> <http://ctro/data#hasSdDevResValue> \"1 . 36\"."
52, Percentage, 1622, 1623, "%", "", 
172, Mean, 1648, 1652, "mean", "", "<http://ctro/data#Mean_36426> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_36424> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_36426>."
143, DiffGroupAbsValue, 1691, 1699, "- 1 . 01", "", "<http://ctro/data#DiffBetweenGroups_37604> <http://ctro/data#hasDiffGroupAbsValue> \"- 1 . 01\"."
54, Percentage, 1700, 1701, "%", "", 
55, ConfIntervalDiff, 1704, 1732, "95 % CI - 1 . 26 to - 0 . 76", "", "<http://ctro/data#DiffBetweenGroups_37604> <http://ctro/data#hasConfIntervalDiff> \"95 % CI - 1 . 26 to - 0 . 76\"."
56, PvalueDiff, 1735, 1746, "P < 0 . 001", "", "<http://ctro/data#DiffBetweenGroups_37604> <http://ctro/data#hasPvalueDiff> \"P < 0 . 001\"."
57, HbA1c_target, 1755, 1780, "target A1C ( < or = 7 % )", "", "<http://ctro/data#Endpoint_36429> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c_target>."
58, PercentageAffected, 1797, 1799, "34", "", "<http://ctro/data#Outcome_37613> <http://ctro/data#hasPercentageAffected> \"34\"."
59, Drug, 1824, 1834, "benfluorex", "", 
60, PercentageAffected, 1842, 1844, "12", "", "<http://ctro/data#Outcome_37640> <http://ctro/data#hasPercentageAffected> \"12\"."
61, Placebo, 1869, 1876, "placebo", "", 
62, Drug, 1931, 1941, "benfluorex", "", 
173, Mean, 1960, 1964, "mean", "", 
63, FastingPlasmaGlucose, 1965, 1968, "FPG", "", "<http://ctro/data#Endpoint_36434> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#FastingPlasmaGlucose>."
156, DiffGroupAbsValue, 1971, 1979, "- 1 . 65", "", "<http://ctro/data#DiffBetweenGroups_37721> <http://ctro/data#hasDiffGroupAbsValue> \"- 1 . 65\"."
64, Millimoles_per_litre, 1980, 1988, "mmol / l", "", 
158, PvalueDiff, 1993, 2004, "P < 0 . 001", "", "<http://ctro/data#DiffBetweenGroups_37721> <http://ctro/data#hasPvalueDiff> \"P < 0 . 001\"."
67, EndPointDescription, 2047, 2065, "insulin resistance", "", "<http://ctro/data#EndPointDescription_36440> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_36439> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_36440>."
180, ObservedResult, 2115, 2180, "Serious adverse events were more frequent in the benfluorex group", "", "<http://ctro/data#Outcome_37731> <http://ctro/data#hasObservedResult> \"Serious adverse events were more frequent in the benfluorex group\"."
179, EndPointDescription, 2123, 2137, "adverse events", "", "<http://ctro/data#EndPointDescription_36445> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_36444> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_36445>."
68, Drug, 2164, 2174, "benfluorex", "", 
69, ConclusionComment, 2242, 2446, "Benfluorex as an add - on therapy was superior to placebo in lowering A1C with a between - group difference of 1 % in type 2 diabetic patients whose disease was insufficiently controlled with sulfonylurea", "", "<http://ctro/data#ClinicalTrial_36397> <http://ctro/data#hasConclusionComment> \"Benfluorex as an add - on therapy was superior to placebo in lowering A1C with a between - group difference of 1 % in type 2 diabetic patients whose disease was insufficiently controlled with sulfonylurea\"."
70, Drug, 2242, 2252, "Benfluorex", "", 
71, Placebo, 2292, 2299, "placebo", "", 
72, HbA1c, 2312, 2315, "A1C", "", 
45707, DiffGroupRelValue, 2353, 2354, "1", "", 
164, Type2Diabetes, 2360, 2375, "type 2 diabetic", "", 
74, Sulfonylureas, 2434, 2446, "sulfonylurea", "", 
181, ConclusionComment, 2447, 2513, "alone and in whom metformin was contraindicated or not tolerated .", "", "<http://ctro/data#ClinicalTrial_36397> <http://ctro/data#hasConclusionComment> \"alone and in whom metformin was contraindicated or not tolerated .\"."
75, Metformin, 2465, 2474, "metformin", "", 
77, PMID, 2576, 2584, "16505498", "", "<http://ctro/data#Publication_36381> <http://ctro/data#hasPMID> \"16505498\"."
